Agoracom Blog Home

Archive for the ‘All Recent Posts’ Category

VIDEO: Royal Helium’s (RHC TSX:V RHCCF: OTC) Massive Discovery in Saskatchewan Could Be In Production By Year End

Posted by AGORACOM-Eric at 4:48 PM on Tuesday, September 21st, 2021

Helium is a high tech gas, with many uses in multiple high tech applications:

MRI Magnets, Fibre Optic Cables for High Speed Internet, Airbags, Hard Drives, Chips in our Electronics, Cleaning Rocket Fuel Tanks.

The list is varied and demand is inelastic. They don’t function without Helium and world is in short supply, but Royal Helium is quickly proving that they may be the solution.

They have made a discovery, a big one; and in in just one well, and may have already proven up 500 billion cubic feet of inert gas. One Well. One Zone. Over a Million acres of prospective Helium still to be explored.

Royal Helium aimed to deliver a minimum of 1 trillion cubic feet (Tcf) of total inert gas into the market, and this discovery clearly demonstrates they are on their way. With economic concentrations ranging from 0.33% to 0.94%, Royal has a real possibility of commencing production by the end of the year.

Royal discovered a 40m zone in Climax 3 and tested, cored and recovered the rock to test porosity to see how the gas flows. Expecting to find something similar in Climax 4, they actually found something bigger, much bigger. A zone 120m thick. About the size of twelve story building, containing elevated concentrations of Helium suitable for production. A normal producing area is considered high within a 5 meter range. Royal has a discovery multiples of the global average and they are still very early in their exploration process.

Sit back and enjoy this #SmallCap discovery as Andrew Davidson, CEO & Chairman of Royal Helium RHC: TSXV explains how Royal is putting Saskatchewan on the map with some of the highest historical helium showings while simultaneously developing Climax Nazare without delay or compromise.

The Roundup – @Novamind_Inc $NM.ca $NVMDF $RVV.ca $MMED $PSYC.ca $FTRP.ca $CMPS $NUMI.ca

Posted by AGORACOM-JC at 9:22 AM on Saturday, September 18th, 2021

A weekly summary of Novamind news and media, including the announcement of our selection as a research site for Karuna Therapeutics.

September 14, 2021

What Is Psycholytic Ketamine Assisted Psychotherapy?

In this episode of the Psychedelic Therapy Frontiers podcast, Dr. Steve Thayer and Dr. Reid Robison are joined by returning guest, Vhari Macbeth to discuss psycholytic ketamine-assisted psychotherapy (KAP).

Learn more, subscribe and catch up on previous episodes you may have missed at psychedelictherapyfrontiers.com

View all media

Novamind to Serve as Research Site for Karuna Therapeutics Late-Stage Clinical Trial

We are pleased to announce that our wholly owned subsidiary, Cedar Clinical Research has been selected as a research site for a clinical trial sponsored by Karuna Therapeutics, Inc., a clinical-stage neuroscience biopharmaceutical company

The phase III study will evaluate the investigational therapy KarXT for the treatment of schizophrenia, a serious and potentially disabling condition affecting approximately 20 million people worldwide.

Dr. Reid Robison, Novamind’s Chief Medical Officer and Principal Investigator at CCR said, “We need more innovation in this field and I’m hopeful to see compounds like KarXT that have new ways of acting on the brain and the potential for improved efficacy and side effect profiles.”

September 13, 2021

View all press releases

Legalising Illicit Therapies: Why Psychedelics Could Be The Most Important Mental Health Breakthrough Of The 21st Century

As psychedelics continue to break free from the stigma surrounding them, more and more people are seeing the promise these drugs have in changing the way we treat mental health. “Recent trials are showing that psychedelics are proving not only successful but also incredibly effective when stacked up against traditional forms of treatment, with one recent trial reporting that they are up to four times more effective than antidepressants.”

The DEA Seeks To Increase Federal Production Limits For Psilocybin And Marijuana Research

In a big step forward for psychedelic research, the DEA is set to increase limits for psilocybin. From the DEA: “DEA firmly believes in supporting regulated research of schedule I controlled substances.” We look forward to increased research and have a dedicated psychedelic contract research organization (CRO) in Cedar Clinical Research, capable of studying promising new treatments.

Follow @novamind_inc on Instagram

For further information, email us: 
[email protected]

Was this email forwarded to you?
Subscribe to our weekly newsletter

VIDEO – Boosh (VEGI: CSE) An Award Winning Plant-Based Comfort Food Company With Products In ~ 400 Stores Nationwide

Posted by AGORACOM-JC at 5:42 PM on Monday, September 13th, 2021

If you’ve ever thought to yourself “how great would it be if my favourite comfort foods could only be healthier” than meet Boosh … an Award Winning Plant-Based Comfort Food Company whose products include:

  • Mac N Cheese and Peas
  • Veggie Bolognese
  • and other “Heat and Eat” delicious comfort foods that are 
    • Multiple Award winning 
    • 100% Plant-based, GMO and Gluten Free

The company has only been a public entity for a few months and it’s already making waves. 

  • Expanded to approximately 400 stores in less than 2 years including 
    •  Whole Foods, Safeway, Metro, IGA, Choices + many other retailers
  • An alliance with Beyond Meat 
  • Distributed by UNFI – one of the largest distributors in North America
  • Expanded into refrigerated section with new SKUs

Growth of The Plant-Based food Market is Undeniable…

The plant-based food market is expected to grow at a CAGR of 11.9% from 2020 to 2027 to reach $74.2 billion by 2027 according to ResearchAndMarkets.com. 

Watch this powerful interview with Boosh CEO Jim Pakulis.

VIDEO: Fabled Silver Gold $FCO $FBSGF President & CEO Peter Hawley Discusses How Grade is King with Latest High Grade Intercepts $FCO $FBSGF $RDU $KTN $GMBXF $EDR

Posted by AGORACOM-Eric at 10:06 PM on Saturday, September 11th, 2021

Fabled Silver Gold (FCO TSXV) ( FBSGF: OTC ) controls 100% of the Santa Maria mine gold and silver property in Mexico.

It is a high grade silver gold property that is situated right in the middle of the Mexican Epithermal silver gold belt that has reportedly produced more silver than any other equivalent area in the entire planet.

To say it’s a mining friendly jurisdiction is an understatement.

Multiple major operators are in the vicinity and Santa Maria already has a silver equivalent 43-101 of 3.2m ounces, but is adding to that not only in tonnage, but in grade. High grade; and that only improves a future 43-101.

High grade mines pay back Capital costs faster, making them economic and profitable.

Check out these intercepts from the last 4 press releases that include not only high grade silver but a new gold discovery as well:

Aug 17: New Gold System, Hits Lower Feeder, which Returns 580.01 g/t Silver Eq, PLUS 19.90% Lead, 5.18% Zinc and 1.29% Copper

Aug 23rd: Intercepts Gold Bearing Sheeted Vein Structure Over A True Width of 150 Meters

Sept 1st: New High Grade Vein Breccia Outside Santa Maria Structure Boundaries, with Grades High As 1,072.73 g/t Ag Eq and..

Sept: 8th: Fabled Hits Supergene Quartz Breccia Over 1.35 Meters Grading 689.56 g/t Ag Eq

Fabled is intent on proving Santa Maria is bigger and of potentially higher grade than the market understands, and is well on its way. Grade is king an the mines with the best grade get developed first.

Santa Maria is already a proven past producer, the development progress made by Fabled is only increasing the potential re-development, but with potential better economics. Sit back and enjoy as Peter Hawley President & CEO explains the importance of how high grade intercepts improve a mines chance of being developed.

VIDEO – FOBI AI Channel Partnerships With Shopify and Lightspeed + Anticipated Pilot News Set The Table For Big 2021 Finish

Posted by AGORACOM-JC at 5:13 PM on Tuesday, September 7th, 2021
Fobi AI Inc.

FOBI AI is a global leader in providing real-time data analytics through artificial intelligence to drive customer activation and engagement for enterprise level retailers.

More than just lip service, these are just a sample of the major milestones reached by $FOBI as of the end of July:

  • Strategic Alliance with global data leader – NeilsonIQ – to “Transform Retail Sector”
  • A partnership with NTT DATA, a top-ranked global IoT services company, and subsidiary of Nippon Telegraph and Telephone, the world’s 4th largest telecom company, ranked 55th In Fortune Global 500. 
  • Approved for Oracle Partner Network
  • Pilot Projects with Sobeys, TELUS, Certas and other national level retailers
  • Multi-Year Direct Seller Agreement With TELUS, in which TELUS resells FOBI solutions to national business customers….
  • and so much more

But if this wasn’t enough $FOBI announced the following in the last 10 days while the rest of us were on vacation:

FOBI Completes Integration With Lightspeed To Provide Real-Time POS Data Aggregation And Analytics To Lightspeed Customer

  • Lightspeed has 140,000 “real world” point of sale customers that generated $30 BILLION in transactions last year

FOBI Completes Shopify Integration With The Launch Of The Fobi App And Now Live In The Shopify App Store Offering Real-Time Data Analytics Solution To Over 1.7 Million Global Retailers

  • Shopify has 1.7 Million e-commerce customers that generated $120 BILLION is gross merchandising volume last year

Investors who were excited by the announcements may have even further cause to celebrate following this interview with CEO Rob Anson.

The Roundup – @Novamind_Inc $NM.ca $NVMDF $RVV.ca $MMED $PSYC.ca $FTRP.ca $CMPS $NUMI.ca

Posted by AGORACOM-JC at 8:59 AM on Saturday, August 28th, 2021

A weekly summary of Novamind news and media

August 24, 2021

Pairing Ketamine with EMDR & Other Therapy Methods

In this episode of the Psychedelic Therapy Frontiers podcast, Dr. Steve Thayer and Dr. Reid Robison are joined by Bob Mcnutt to discuss how ketamine is combined with a variety of psychotherapy modalities, particularly Eye Movement Desensitization and Reprocessing (EMDR).

Learn more, subscribe and catch up on previous episodes you may have missed at psychedelictherapyfrontiers.com

View all media

Peace Blockade

Erinn Baldeschwiler is just “looking for a sense of peace as she dies.” Baldeschwiler has terminal breast cancer and has tried to turn to psilocybin therapy, under the Right to Try Act, to help. But it hasn’t been that simple. It’s why she and other patients in similar situations are taking it to the courtroom. The case is set for next month, with the potential for a decision to come as early as this fall. “For Baldeschwiler, a safe and caring treatment plan involving psilocybin may be what helps her find peace. For her, now is the time to act — she doesn’t have much of it to spare.”

New UW Center to Study Emerging Field of Psychedelic Compounds for Medical Treatments

Exciting news out of Wisconsin as the Transdisciplinary Center for Research in Psychoactive Substances is announced. “Four clinical trials in phases 1 to 3 are currently underway at UW–Madison to prepare for submitting applications for new drugs to the Food and Drug Administration.” The center has stated it will seek to include more minorities and marginalized groups in their research.

Researchers Work to Integrate Psychedelic Drug and Music Therapies Using Technology

Music and psychedelics have a long history together. And now, some tech companies “are designing music to help you get the most out of your trip,” creating music to enhance the therapeutic potential of psychedelics.

Follow @novamind_inc on Instagram

VIDEO – HPQ Breakthrough Green Hydrogen Launch Provides “Power Plant” To Take Silicon Production Plants Global … While Launching Commercial Hydrogen Products

Posted by AGORACOM-JC at 4:05 PM on Tuesday, August 24th, 2021

HPQ Silicon Resources $HPQ $HPQFF is a Quebec-based company that is developing high value-added silicon products that are sought after by battery and electric vehicle manufacturers – but nobody has yet delivered – until now.

If that sounds a lot like what other small companies are saying lately, $HPQ differentiates itself as a leader of the pack thanks to the following:

As such, HPQ firmly believes its silicon products will play an important role in the renewable energy revolution. To this end, the Company had also announced some small but important initiatives in Hydrogen power generation over the last 12 months … but that initiative was significantly accelerated today when HPQ announced HPQ Launches Revolutionary and Breakthrough Green Hydrogen Extraction Technology Venture

How much acceleration? Try “SCALABLE WITH NO LIMITS”

“EBH2 is scalable with no limits.  It can power a small domestic generator up to ships, factories, buildings, cryptocurrency mines with high energy consumption and even cities.”

EBH2 believes it can scale to power the planned high purity silicon and Nano silicon production by HPQ. If successful, HPQ proposes to bundle the energy production capability of EBH2 systems with its silicon production to further reduce the environmental footprint of its developing high purity silicon, nano powders, and other Renewable Energy products.  Moreover, if successful, EBH2 would provide HPQ with “power plant” capabilities that would allow it to produce its products anywhere on the planet.

If that wasn’t enough HPQ added the following:

“all the while opening up new, and massive addressable markets for a system that can produce cheaply green hydrogen, on demand …. The Agreement establishes the terms of the creation of a new Joint venture Company (“NEWCO”) owned by HPQ and EBH2 that will market, sell and service EBH2 systems and products in North America (Canada, Mexico, and the United States).  …. units could readily replace solar panels or standby generators for homeowners.”

Watch this great interview with $HPQ CEO Bernard Tourillon to get the full picture on next steps!

VIDEO – With First New Clinic Launches In Ontario Imminent, Empower Clinics Is Sitting On A Launchpad That Will Keep The Company Flying Through 2022 And Beyond

Posted by AGORACOM-JC at 4:04 PM on Monday, August 16th, 2021

In an interview just over a month ago, Empower Clinics CEO Steve McAuley talked about how the Company is in full-blown growth mode that were best summarized as follows:

“Multiple opportunities have been percolating and I’m going to turn up the heat”

To this added seeing 

“substantially higher market cap” for the Company, as well as, growth that will be “deserving of an uplist”.

Today McAuley and the team at Empower backed up those words with this announcement:

“The Company can now confirm the first new clinic launches will take place in September – location and ribbon cutting ceremonies to be announced – with rollouts of further locations continuing on a regular basis from that point forward.”

In today’s interview McAuley takes shareholders through a detailed overview of the foundation that has now been built, ready to launch and strong enough to catapult Empower into a completely new orbit.
Watch this great interview.  Welcome to the launch pad.   

VIDEO – Draganfly Has Record Revenue, Tier-1 Clients and Recent NASDAQ Listing

Posted by AGORACOM-JC at 4:19 PM on Monday, August 9th, 2021

Most of us know drones for their recreational uses or perhaps even as simple commercial applications for things like real estate videos. 

But the fact of the matter is that drone usage is about to go parabolic with huge corporations adopting them for a wide-use of applications that most never dreamed of such as:

  • To provide Internet connections in remote locations. 
  • To collect crowd data.

In short, the drone industry is booming in ways people can’t imagine because the industry is shifting from the drones themselves (hardware) to drone technology and solutions (software)… and the one company that is delivering the most challenging applications is Draganfly Inc. (DPRO: NASDAQ) (DPRO: CSE)

DraganFly is an award-winning drone manufacturer and technology developer that is actually delivering some pretty incredible achievements, milestones and even history:

  • Established in 1998 DFLY is considered the oldest commercial drone company in the world
  • Built the first drone that saved a life
  • Boasts the first drone to be inducted into the Smithsonian National Air & Space Museum
  • Developing a Vaccine Drone Delivery Payload System (it’s way more complicated than just transporting vaccines)
  • Detect infectious conditions in a person from a distance of 190 feet
  • Conduct phenotyping, data collection and analysis by the USDA

Clients include:

  • NASCAR
  • Ford
  • Warner Brothers
  • Suncor Energy
  • Shell
  • Redbull
  • Government of Canada 
  • Ontario Provincial Police, 
  • Australian Federal Police, 
  • Royal Canadian Mounted Police, 
  • Illinois State Police,
  • Shell
  • Dow 

If you want ultra-cool consider that DFLY’s Vital Intelligence technology was selected for implementation by Knightscope, a leader in a leader in autonomous robot security capabilities.  

All of this has translated into financial success with 2020 Revenue hitting $4.36M up 216% … and now a record Q1 with $1.53M up 210%.

With all of this under the Company’s belt, it’s easy to see why the company recently uplisted to the NASDAQ.

If you believe in the massive parabolic growth in the use of drones for almost everything we do in this world, or want to learn, then watch / listen to this powerful interview with Draganfly CEO and Chairman, Cameron Chell.

The Roundup – @Novamind_Inc $NM.ca $NVMDF $RVV.ca $MMED $PSYC.ca $FTRP.ca $CMPS $NUMI.ca

Posted by AGORACOM-JC at 9:03 AM on Saturday, August 7th, 2021

A weekly summary of Novamind news and media, including the announcement of our new VP of Communications and much more.

FEATURES August 6, 2021

A Step Forward for Mental Health

Where other treatments for depression have failed, ketamine has changed lives. Chief Medical Officer Dr. Reid Robison spoke to Leafly about how ketamine is changing mental healthcare.

“Ketamine is now emerging as a powerful catalyst to accelerate the healing and recovery process in individuals suffering from a wide array of mental health symptoms.”

OPINION August 3, 2021

Why Do We Self-Sabotage?

In this episode of the Psychedelic Therapy Frontiers podcast, Dr. Steve Thayer, Vhari MacBeth, and Derick Moody explore the curious phenomenon of self-sabotage.

Learn more, subscribe and catch up on previous episodes you may have missed at psychedelictherapyfrontiers.com 

FEATURES August 3, 2021

Predicting the Boom

Business insider covers our business model and why VCs are bullish on the psychedelic boom.

“2021 and the vast majority of 2022 will be laying infrastructure groundwork for the coming global industry to emerge”

View all media

Novamind Strengthens Mental Health Expertise, Adds Communications Leader

We are pleased to announce the appointment of Samantha DeLenardo as Vice President, Communications to lead Novamind’s communications, marketing and investor relations.

“At Novamind, we care deeply about the clients and families we serve,” said DeLenardo. “We are prepared to meet this transformative moment for psychedelics and mental health, thanks in large part to the courage and years of advocacy by people with lived expertise and medical practitioners. Novamind understands both the responsibility and opportunity before us, and I look forward to sharing the Company’s story with the world.”

August 6, 2021

View all press releases

Usona Institute Breaks Ground for Global Center in Psychedelic Science

In a big step forward for psychedelics, Usona Institute announced the groundbreaking of a Global Center in Psychedelic Science. The campus will “support a blend of disciplines in psychedelic science and education.” It’s another example of momentum building around the truly extraordinary therapeutic potential of psychedelics.

TheraPsil’s Proposed ‘Access to Psilocybin for Medical Purposes Regulations’

Words have not been minced. CEO Spencer Hawkswell comments on the current exemptions for the terminally ill in Canada, “We are going to be lobbying hard to get those regulations set into law to make sure that Canadians can realize their rights to psilocybin.” We look forward to that access expanding to all Canadians.

Follow @novamind_inc on Instagram

 
 

For further information, contact:

Bill Mitoulas
Investor Relations
Telephone: +1 (416) 479 9547
Email: [email protected]